Godavari Drugs Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 765253,
    "name": "Godavari Drugs",
    "stock_name": "Godavari Drugs",
    "full_name": "Godavari Drugs Ltd",
    "name_url": "stocks-analysis/godavari-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "98.11",
    "chg": -3.95,
    "chgp": "-3.87%",
    "dir": -1,
    "prev_price": "102.06",
    "mcapval": "73.88 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530317,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE362C01012",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": "10.52 k",
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/godavari-drugs-765253-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Godavari Drugs Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-is-rated-strong-sell-3784488",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/GodavariDrugsLt_mojoScore_3784488.png",
        "date": "2026-01-07 10:10:23",
        "description": "Godavari Drugs Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 February 2025, reflecting a reassessment of the company’s outlook. However, the analysis and financial metrics presented here are based on the stock’s current position as of 07 January 2026, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "Godavari Drugs Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-ltd-is-rated-strong-sell-3769702",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugsLt_mojoScore_3769702.png",
        "date": "2025-12-25 15:12:53",
        "description": "Godavari Drugs Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 February 2025, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 25 December 2025, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "Godavari Drugs Stock Hits 52-Week Low at Rs.69.7 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-falls-to-52-week-low-of-rs697-amidst-continued-weakness-3753811",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugs_priceRelatedfactors_3753811.png",
        "date": "2025-12-09 11:23:32",
        "description": "Godavari Drugs has reached a new 52-week low of Rs.69.7, marking a significant decline in its stock price amid a challenging market environment and subdued financial performance over the past year."
      },
      {
        "title": "Godavari Drugs Stock Falls to 52-Week Low of Rs.70.31 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-stock-falls-to-52-week-low-of-rs7031-amid-continued-weak-performance-3751223",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugs_priceRelatedfactors_3751223.png",
        "date": "2025-12-08 11:00:57",
        "description": "Godavari Drugs has reached a new 52-week low of Rs.70.31 today, marking a significant decline in its stock price amid ongoing downward momentum. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market challenges over the past year."
      },
      {
        "title": "Godavari Drugs Stock Falls to 52-Week Low of Rs.70.31 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-stock-hits-52-week-low-amidst-continued-downtrend-3751222",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugs_priceRelatedfactors_3751222.png",
        "date": "2025-12-08 11:00:37",
        "description": "Godavari Drugs has reached a new 52-week low of Rs.70.31, marking a significant decline in its stock price amid ongoing downward momentum. The pharmaceutical and biotechnology company’s shares have been under pressure, reflecting a series of financial and market challenges over the past year."
      },
      {
        "title": "Godavari Drugs Stock Falls to 52-Week Low of Rs.70.31 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-falls-to-52-week-low-amid-continued-weak-performance-3751221",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugs_priceRelatedfactors_3751221.png",
        "date": "2025-12-08 11:00:21",
        "description": "Godavari Drugs has reached a new 52-week low of Rs.70.31, marking a significant decline in its stock price amid ongoing downward momentum. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market challenges over the past year."
      },
      {
        "title": "Godavari Drugs Sees Revision in Market Evaluation Amidst Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/godavari-drugs-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-trends-3750166",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugs_mojoScore_3750166.png",
        "date": "2025-12-07 10:10:03",
        "description": "Godavari Drugs has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The pharmaceutical microcap’s recent assessment highlights a cautious stance driven by subdued sales growth, persistent negative earnings, and bearish trading patterns."
      },
      {
        "title": "Godavari Drugs Falls to 52-Week Low of Rs.72.11 Amidst Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-stock-hits-52-week-low-at-rs7211-amidst-continued-downtrend-3748950",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugs_priceRelatedfactors_3748950.png",
        "date": "2025-12-05 11:52:55",
        "description": "Godavari Drugs has reached a new 52-week low of Rs.72.11, marking a significant decline in its stock price amid a challenging market environment and subdued financial performance over the past year."
      },
      {
        "title": "Godavari Drugs Falls to 52-Week Low of Rs.73.2 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/godavari-drugs-stock-hits-52-week-low-amidst-continued-downtrend-3740887",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GodavariDrugs_priceRelatedfactors_3740887.png",
        "date": "2025-12-02 09:26:41",
        "description": "Godavari Drugs has reached a new 52-week low of Rs.73.2, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market factors that have influenced its performance."
      }
    ],
    "total": 152,
    "sid": "765253",
    "stock_news_url": "https://www.marketsmojo.com/news/godavari-drugs-765253"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Preferential Issue",
      "datetime": "15-Jan-2026",
      "details": "Outcome of the Board meeting held on 15.01.2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Meeting Held On 15.01.2026",
      "datetime": "15-Jan-2026",
      "details": "Outcome of the Board meeting held on 15.01.2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Options Of Consideration Of Fund-Raising Proposal",
      "datetime": "12-Jan-2026",
      "details": "Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/01/2026 inter alia to consider and approve 1. To consider and evaluate a proposal for raising funds through the issuance of one or more instruments including equity shares warrants convertible into equity shares or other securities by way of preferential issue private placement or any other permissible mode(s) in accordance with the applicable provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018 and other applicable laws subject to necessary approvals including approval of the shareholders and other statutory/ regulatory authorities as may be required.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Godavari Drugs Ltd is Rated Strong Sell

2026-01-07 10:10:23

Godavari Drugs Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 February 2025, reflecting a reassessment of the company’s outlook. However, the analysis and financial metrics presented here are based on the stock’s current position as of 07 January 2026, providing investors with the latest insights into its performance and prospects.

Read full news article

Godavari Drugs Ltd is Rated Strong Sell

2025-12-25 15:12:53

Godavari Drugs Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 10 February 2025, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 25 December 2025, providing investors with the latest insights into its performance and prospects.

Read full news article

Godavari Drugs Stock Hits 52-Week Low at Rs.69.7 Amidst Prolonged Downtrend

2025-12-09 11:23:32

Godavari Drugs has reached a new 52-week low of Rs.69.7, marking a significant decline in its stock price amid a challenging market environment and subdued financial performance over the past year.

Read full news article

Godavari Drugs Stock Falls to 52-Week Low of Rs.70.31 Amidst Continued Downtrend

2025-12-08 11:00:57

Godavari Drugs has reached a new 52-week low of Rs.70.31 today, marking a significant decline in its stock price amid ongoing downward momentum. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market challenges over the past year.

Read full news article

Godavari Drugs Stock Falls to 52-Week Low of Rs.70.31 Amidst Prolonged Downtrend

2025-12-08 11:00:37

Godavari Drugs has reached a new 52-week low of Rs.70.31, marking a significant decline in its stock price amid ongoing downward momentum. The pharmaceutical and biotechnology company’s shares have been under pressure, reflecting a series of financial and market challenges over the past year.

Read full news article

Godavari Drugs Stock Falls to 52-Week Low of Rs.70.31 Amidst Continued Downtrend

2025-12-08 11:00:21

Godavari Drugs has reached a new 52-week low of Rs.70.31, marking a significant decline in its stock price amid ongoing downward momentum. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market challenges over the past year.

Read full news article

Godavari Drugs Sees Revision in Market Evaluation Amidst Challenging Fundamentals

2025-12-07 10:10:03

Godavari Drugs has experienced a revision in its market evaluation reflecting ongoing challenges in its financial and technical outlook. The pharmaceutical microcap’s recent assessment highlights a cautious stance driven by subdued sales growth, persistent negative earnings, and bearish trading patterns.

Read full news article

Godavari Drugs Falls to 52-Week Low of Rs.72.11 Amidst Prolonged Downtrend

2025-12-05 11:52:55

Godavari Drugs has reached a new 52-week low of Rs.72.11, marking a significant decline in its stock price amid a challenging market environment and subdued financial performance over the past year.

Read full news article

Godavari Drugs Falls to 52-Week Low of Rs.73.2 Amidst Continued Downtrend

2025-12-02 09:26:41

Godavari Drugs has reached a new 52-week low of Rs.73.2, marking a significant decline in its stock price amid a sustained downward trend over recent sessions. The pharmaceutical company’s shares have been under pressure, reflecting a series of financial and market factors that have influenced its performance.

Read full news article

View All News